Metraipolis › archive › dc_660be97553c8
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial — Europe PMC PMID:40910183
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40910183
- DOI
- 10.1111/1753-0407.70152
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:59:06.827Z
- SHA-256 of the archived text
b3baf203c08786928ead18b0ea41c7fd13f0de7e268936be0127e77e60b61b91- Stable URL of this page
https://metraipolis.com/documento/dc_660be97553c8
How to cite
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial — Europe PMC PMID:40910183 — Europe PMC (en), https://europepmc.org/article/MED/40910183 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_660be97553c8 (Metraipolis archive dc_660be97553c8, sha256 b3baf203c08786928ead18b0ea41c7fd13f0de7e268936be0127e77e60b61b91)
BibTeX
@misc{dc660be97553c8,
title = {Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial — Europe PMC PMID:40910183},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40910183},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_660be97553c8; sha256 b3baf203c08786928ead18b0ea41c7fd13f0de7e268936be0127e77e60b61b91},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40910183. Agents can read the archived copy with the MCP tool read_document.